{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:41:00Z","timestamp":1778456460359,"version":"3.51.4"},"reference-count":45,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1021\/acs.molpharmaceut.2c00555","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T13:56:58Z","timestamp":1668434218000},"page":"758-766","source":"Crossref","is-referenced-by-count":14,"title":["First-in-Patient Dose Prediction for Adeno-Associated Virus-Mediated Hemophilia Gene Therapy Using Allometric Scaling"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0416-2731","authenticated-orcid":true,"given":"Peng","family":"Zou","sequence":"first","affiliation":[{"name":"Quantitative Clinical Pharmacology, Daiichi Sankyo, Inc., 211 Mt. Airy Road, Basking Ridge, New Jersey07920, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"ref1\/cit1","unstructured":"Guidance for Industry: Considerations for the Design of Early-Phase\nClinical Trials of Cellular and Gene Therapy Products\n                      ; Food and Drug Administration, 2015. https:\/\/www.fda.gov\/media\/106369\/download."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0642-9"},{"key":"ref3\/cit3","author":"Philippidis A.","year":"2021","journal-title":"Genet. Eng. Biotechnol. News"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12597"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00413-6"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-021-00678-7"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2269"},{"key":"ref9\/cit9","unstructured":"Tang, F.; Liao, M.; Han, L.Application of Gene Efficiency Factor to Adeno-Associated Virus (AAV)-Based Hemophilia A Gene Therapy for Clinical Dose Selection.\n                      American Association of Pharmaceutical Scientists National Biotechnology Conference 2022, Anaheim, CA\n                      ; poster number W1230-01-01."},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.012579799"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12586"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02539.x"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3923"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/nm1358"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1038\/nm1549"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.137"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.274"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2011.104"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.202"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4035"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010181"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108046"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1042\/bj3120163"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407309"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137648"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3296"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-804419"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118256"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14391"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908490"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708483"},{"key":"ref32\/cit32","unstructured":"Pipe, S. W.; Hay, C.; Sheehan, J.; Lissitchkov, T.; Coppens, M.; Eichler, H.; Weigmann, S.; Ferrante, F.Evolution of AAV Vector Gene Therapy is Ongoing In Hemophilia. Will the Unique Features of BAY 2599023 Address the Outstanding Needs?\n                      ISTH 2021 Congress\n                      , Abstract PB0652. https:\/\/abstracts.isth.org\/abstract\/evolution-of-aav-vector-gene-therapy-is-ongoing-in-hemophilia-will-the-unique-features-of-bay-2599023-address-the-outstanding-needs\/."},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104205"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-462200"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.03.006"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.12.009"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.080"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.11.005"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1038\/nature12875"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.2174\/1566523215666150929110424"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666666"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-370-7_11"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.02.010"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90166-3"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.2c00555","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.2c00555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:00:54Z","timestamp":1682589654000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.2c00555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1021\/acs.molpharmaceut.2c00555"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00555","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.05.498837","asserted-by":"object"}]},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}